About
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Guided by our values, we are an impact-driven organization that improves care in every setting – one product, one partner, one patient at a time.
Through our core commitments, we are leveraging our scale for the greater good, such as serving the needs of our stakeholders, donating back to our communities, protecting our planet, working with policymakers, and more.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportOur businesses bring together leading technologies, innovative solutions and hands-on expertise to support the entire healthcare ecosystem.
We distribute pharmaceuticals and medical supplies to healthcare settings across North America, from pharmacies and hospitals to doctors’ offices and clinics.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
We provide research, insights, technologies and other support to help address challenges in cancer and specialty care.
We provide a suite of solutions designed to address access, affordability and adherence challenges by bridging the gaps between biopharma companies, pharmacies, providers, and payers to help patients get on and stay on their medications.
We offer solutions that enable employers, payers, health-plan brokers and government agencies to provide lower-cost options for prescription medications and therapies.
We help to ensure the financial wellbeing of pharmacies and health systems and support a stable work environment for their employees.
Every year, we publish updates to our commitments through our Impact Report.
Download Our Impact ReportSAN FRANCISCO, June 15, 2023 — McKesson Ventures’ managing director Dave Schulte has been recognized by GrowthCap as one of the top 25 healthcare investors for 2023. This award acknowledges healthcare investors who have demonstrated high levels of sustained investment performance, and who are recognized as leaders by portfolio company CEOs, industry peers and colleagues.
For two decades, Schulte has been investing in innovative healthcare technology and services businesses focused on improving data insights, health outcomes, and access to care. Schulte joined McKesson Ventures in 2014 as a managing director after 10 years leading Kaiser Permanente Ventures. He took the helm of McKesson Ventures in 2020, from Tom Rodgers, McKesson EVP and Chief Strategy Officer, and now leads one of the most respected and diverse investment teams in healthcare venture.
“This recognition underscores the success of our fund and appreciation for the value of partnering with McKesson Ventures,” Schulte said. “I am proud of the team we have built, the entrepreneurs we have supported and the impact that we have had on healthcare innovation. We have never been more optimistic about the potential for entrepreneurial companies to advance health outcomes and our ability to help them succeed.”
During his tenure at McKesson Ventures, Schulte has helped build out one of the industry’s strongest pharma services portfolios, which include his investments in Komodo Health, Shyft Analytics (acquired by Medidata) and Saama. In addition, he has also led investments in several other category-defining businesses in value-based care including Aledade and Landmark (acquired by Optum).
Schulte began his career in investment banking at JP Morgan, Piper Jaffray, and UBS. He is a graduate of St. John’s University and received a Masters in Public Policy from Harvard Kennedy School.
About McKesson Ventures
McKesson Ventures is a strategic venture firm backed by McKesson Corporation focusing on early and growth stage digital health and tech-enabled healthcare services companies. McKesson Ventures targets companies that both catalyze and benefit from the key changes taking place in the U.S. healthcare landscape. McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Visit www.mckessonventures.comto learn more.
Investors and Financial Media
Holly Weiss
972-969-9174
Holly.Weiss@McKesson.com